Parallax Volatility Advisers’s Tenet Healthcare THC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-12,962
| Closed | -$1.64M | – | 2126 |
|
|
2024
Q4 | $1.64M | Sell |
12,962
-5,251
| -29% | -$781K | ﹤0.01% | 1181 |
|
|
2024
Q3 | $3.03M | Buy |
+18,213
| New | +$2.75M | 0.01% | 984 |
|
|
2023
Q4 | – | Sell |
-11,834
| Closed | -$750K | – | 2493 |
|
|
2023
Q3 | $780K | Buy |
11,834
+3,220
| +37% | +$241K | ﹤0.01% | 1460 |
|
|
2023
Q2 | $701K | Sell |
8,614
-4,868
| -36% | -$347K | ﹤0.01% | 1538 |
|
|
2023
Q1 | $801K | Buy |
+13,482
| New | +$749K | ﹤0.01% | 1590 |
|
|
2022
Q1 | – | Sell |
-141,922
| Closed | -$11.7M | – | 3381 |
|
|
2021
Q4 | $11.6M | Sell |
141,922
-92,918
| -40% | -$6.79M | 0.01% | 837 |
|
|
2021
Q3 | $15.6M | Sell |
234,840
-11,086
| -5% | -$786K | 0.01% | 752 |
|
|
2021
Q2 | $16.5M | Buy |
245,926
+11,175
| +5% | +$693K | 0.01% | 706 |
|
|
2021
Q1 | $12.2M | Buy |
234,751
+68,493
| +41% | +$3.46M | 0.01% | 853 |
|
|
2020
Q4 | $6.64M | Sell |
166,258
-42,904
| -21% | -$1.38M | ﹤0.01% | 1283 |
|
|
2020
Q3 | $5.13M | Buy |
209,162
+24,772
| +13% | +$633K | ﹤0.01% | 1303 |
|
|
2020
Q2 | $3.34M | Buy |
184,390
+65,671
| +55% | +$1.29M | ﹤0.01% | 1249 |
|
|
2020
Q1 | $1.71M | Sell |
118,719
-18,464
| -13% | -$530K | ﹤0.01% | 1300 |
|
|
2019
Q4 | $5.22M | Buy |
137,183
+74,699
| +120% | +$2.24M | 0.01% | 888 |
|
|
2019
Q3 | $1.38M | Buy |
62,484
+22,434
| +56% | +$478K | ﹤0.01% | 1268 |
|
|
2019
Q2 | $827K | Sell |
40,050
-47,448
| -54% | -$1.09M | ﹤0.01% | 1343 |
|
|
2019
Q1 | $2.52M | Buy |
87,498
+50,344
| +136% | +$1.24M | ﹤0.01% | 916 |
|
|
2018
Q4 | $637K | Buy |
37,154
+9,719
| +35% | +$235K | ﹤0.01% | 1447 |
|
|
2018
Q3 | $781K | Sell |
27,435
-1,362
| -5% | -$45K | ﹤0.01% | 1342 |
|
|
2018
Q2 | $967K | Buy |
+28,797
| New | +$895K | ﹤0.01% | 1105 |
|
|
2018
Q1 | – | Sell |
-97,654
| Closed | -$1.94M | – | 4144 |
|
|
2017
Q4 | $1.48M | Buy |
97,654
+63,329
| +184% | +$891K | ﹤0.01% | 1034 |
|
|
2017
Q3 | $564K | Buy |
34,325
+26,050
| +315% | +$442K | ﹤0.01% | 1223 |
|
|
2017
Q2 | $160K | Sell |
8,275
-17,628
| -68% | -$308K | ﹤0.01% | 1528 |
|
|
2017
Q1 | $459K | Sell |
25,903
-29,573
| -53% | -$549K | ﹤0.01% | 1533 |
|
|
2016
Q4 | $823K | Buy |
55,476
+18,528
| +50% | +$332K | ﹤0.01% | 1311 |
|
|
2016
Q3 | $837K | Buy |
+36,948
| New | +$962K | ﹤0.01% | 1314 |
|
|
2015
Q4 | – | Sell |
-8,865
| Closed | -$291K | – | 3874 |
|
|
2015
Q3 | $327K | Sell |
8,865
-55,745
| -86% | -$2.88M | ﹤0.01% | 1665 |
|
|
2015
Q2 | $3.74M | Buy |
+64,610
| New | +$3.3M | 0.01% | 822 |
|
|
2015
Q1 | – | Sell |
-2,220
| Closed | -$104K | – | 5506 |
|
|
2014
Q4 | $112K | Sell |
2,220
-2,658
| -54% | -$139K | ﹤0.01% | 3369 |
|
|
2014
Q3 | $290K | Buy |
+4,878
| New | +$272K | ﹤0.01% | 2217 |
|
|
2014
Q2 | – | Sell |
-5,969
| Closed | -$270K | – | 4307 |
|
|
2014
Q1 | $256K | Buy |
5,969
+3,195
| +115% | +$141K | ﹤0.01% | 1329 |
|
|
2013
Q4 | $117K | Buy |
+2,774
| New | +$121K | ﹤0.01% | 1754 |
|
Other funds holding THC
GCM
Parallax Volatility Advisers's THC Position: Q1 2025 in Review
Parallax Volatility Advisers sold out of Tenet Healthcare (THC) in Q1 2025, closing a stake of 12,962 shares — an estimated $1.64M sold.
Parallax Volatility Advisers first reported a position in THC in Q4 2013 and held it in 32 quarters. The position peaked at $16.5M in Q2 2021. 567 funds tracked by Wall St. Rank hold THC as of Q1 2025.
- Parallax Volatility Advisers reported no remaining Tenet Healthcare position as of Q1 2025 after selling out during the quarter.
- Parallax Volatility Advisers sold 12,962 Tenet Healthcare shares in Q1 2025, an estimated $1.64M.
- Parallax Volatility Advisers first reported a position in Tenet Healthcare in Q4 2013 and held it in 32 quarters.
- Parallax Volatility Advisers's Tenet Healthcare position peaked at $16.5M in Q2 2021.
- 567 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2025.
Based on Parallax Volatility Advisers's 13F filing for Q1 2025, filed 15 May 2025.